Vortioxetine Hydrobromide contains not less than 98.0% and not more than 102.0% w/w of C18H22N2SHBr calculated on anhydrous basis.

共有 1 個藥物證書使用此成份

渥挺思定氫溴酸鹽
Vortioxetine Hydrobromide

• 申請商: 凱沛爾藥品有限公司
• 適應症: 抗憂鬱劑
• 發證日期: 2023-11-23